Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form

Abstract Background The stability-indicating chromatographic method was developed and validated for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form. The RP-HPLC elution was carried out at 242.0 nm using column Oyster ODS3 (150 × 4.6 mm, 5 µm) isocrat...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rameshwar Gholve, Sanjay Pekamwar, Sailesh Wadher, Tukaram Kalyankar
Formato:	article
Lenguaje:	EN
Publicado:	SpringerOpen 2021
Materias:	Telmisartan Rosuvastatin calcium Forced degradation Solution stability Method validation RP-HPLC Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/a80d278f52394925b9e0d1989259f2d4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a80d278f52394925b9e0d1989259f2d4
record_format	dspace
spelling	oai:doaj.org-article:a80d278f52394925b9e0d1989259f2d42021-11-08T11:04:38ZStability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form10.1186/s43094-021-00369-22314-7253https://doaj.org/article/a80d278f52394925b9e0d1989259f2d42021-11-01T00:00:00Zhttps://doi.org/10.1186/s43094-021-00369-2https://doaj.org/toc/2314-7253Abstract Background The stability-indicating chromatographic method was developed and validated for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form. The RP-HPLC elution was carried out at 242.0 nm using column Oyster ODS3 (150 × 4.6 mm, 5 µm) isocratically, and a mobile phase containing 10 mM phosphate buffer with 1.1 g octane-1-sulfonic acid sodium salt having pH 2.5 (adjusted with 5% OPA) and acetonitrile, with a proportion of 500:500, v/v was pumped through the column maintained at ambient (about 25 °C) temperature with 1.0 mL/min flow rate. The proposed method was validated according to ICH Q2 (R1) guideline. Results Telmisartan and rosuvastatin were eluted at 2.553 min and 4.505 min, respectively. The method is linear from 99.9073 to 299.7218 µg/mL for telmisartan (R 2 = 1.000) and 23.6841 – 71.0522 µg/mL for rosuvastatin (R 2 = 0.999). The average recovery percentage was found 100.51, 99.76, and 99.14% for telmisartan and 99.68, 99.72, and 98.56% for rosuvastatin at three different levels. Results of method repeatability and intermediate precision were found within acceptable limits. Results of solution stability showed that mobile phase was stable for 2 days; standard and sample preparations are stable for 1 day at room temperature as well as in the refrigerator (2–8 °C). Also, forced degradation study results show that method is stability indicating as capable of distinguishing the active analytes peak from the degraded product. Conclusion The developed stability-indicating method is linear in studied concentration range as well as precise, accurate, specific, and robust. Hence, successfully this method can be used for routine analysis and stability study. Graphical abstractRameshwar GholveSanjay PekamwarSailesh WadherTukaram KalyankarSpringerOpenarticleTelmisartanRosuvastatin calciumForced degradationSolution stabilityMethod validationRP-HPLCTherapeutics. PharmacologyRM1-950Pharmacy and materia medicaRS1-441ENFuture Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-15 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Telmisartan Rosuvastatin calcium Forced degradation Solution stability Method validation RP-HPLC Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441
spellingShingle	Telmisartan Rosuvastatin calcium Forced degradation Solution stability Method validation RP-HPLC Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441 Rameshwar Gholve Sanjay Pekamwar Sailesh Wadher Tukaram Kalyankar Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
description	Abstract Background The stability-indicating chromatographic method was developed and validated for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form. The RP-HPLC elution was carried out at 242.0 nm using column Oyster ODS3 (150 × 4.6 mm, 5 µm) isocratically, and a mobile phase containing 10 mM phosphate buffer with 1.1 g octane-1-sulfonic acid sodium salt having pH 2.5 (adjusted with 5% OPA) and acetonitrile, with a proportion of 500:500, v/v was pumped through the column maintained at ambient (about 25 °C) temperature with 1.0 mL/min flow rate. The proposed method was validated according to ICH Q2 (R1) guideline. Results Telmisartan and rosuvastatin were eluted at 2.553 min and 4.505 min, respectively. The method is linear from 99.9073 to 299.7218 µg/mL for telmisartan (R 2 = 1.000) and 23.6841 – 71.0522 µg/mL for rosuvastatin (R 2 = 0.999). The average recovery percentage was found 100.51, 99.76, and 99.14% for telmisartan and 99.68, 99.72, and 98.56% for rosuvastatin at three different levels. Results of method repeatability and intermediate precision were found within acceptable limits. Results of solution stability showed that mobile phase was stable for 2 days; standard and sample preparations are stable for 1 day at room temperature as well as in the refrigerator (2–8 °C). Also, forced degradation study results show that method is stability indicating as capable of distinguishing the active analytes peak from the degraded product. Conclusion The developed stability-indicating method is linear in studied concentration range as well as precise, accurate, specific, and robust. Hence, successfully this method can be used for routine analysis and stability study. Graphical abstract
format	article
author	Rameshwar Gholve Sanjay Pekamwar Sailesh Wadher Tukaram Kalyankar
author_facet	Rameshwar Gholve Sanjay Pekamwar Sailesh Wadher Tukaram Kalyankar
author_sort	Rameshwar Gholve
title	Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
title_short	Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
title_full	Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
title_fullStr	Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
title_full_unstemmed	Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
title_sort	stability-indicating rp-hplc method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
publisher	SpringerOpen
publishDate	2021
url	https://doaj.org/article/a80d278f52394925b9e0d1989259f2d4
work_keys_str_mv	AT rameshwargholve stabilityindicatingrphplcmethoddevelopmentandvalidationforsimultaneousestimationoftelmisartanandrosuvastatincalciuminbulkandintabletdosageform AT sanjaypekamwar stabilityindicatingrphplcmethoddevelopmentandvalidationforsimultaneousestimationoftelmisartanandrosuvastatincalciuminbulkandintabletdosageform AT saileshwadher stabilityindicatingrphplcmethoddevelopmentandvalidationforsimultaneousestimationoftelmisartanandrosuvastatincalciuminbulkandintabletdosageform AT tukaramkalyankar stabilityindicatingrphplcmethoddevelopmentandvalidationforsimultaneousestimationoftelmisartanandrosuvastatincalciuminbulkandintabletdosageform
_version_	1718442363929493504

Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form

Ejemplares similares